Aptamers are oligonucleotide ligands, either RNA or ssDNA, selected for high-affinity binding to molecular targets, such as small organic molecules, proteins or whole microorganisms. While reports of new aptamers are numerous, characterization of their specific interaction is often restricted to the affinity of binding ( K D). Over the years, crystal structures of aptamer-protein complexes have only scarcely become available. Here we describe some relevant technical issues about the process of crystallizing aptamer-protein complexes and highlight some biochemical details on the molecular basis of selected aptamer-protein interactions. In addition, alternative experimental and computational approaches are discussed to study aptamer-protein interactions.
References
[1]
Ellington, A.D.; Szostak, J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346, 818–822.
[2]
Tuerk, C.; Gold, L. Systemic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249, 505–510.
[3]
Paige, J.S.; Wu, K.Y.; Jaffrey, S.R. RNA mimics of green fluorescent protein. Science 2011, 333, 642–646.
[4]
Mehta, J.; van Dorst, B.; Rouah-Martin, E.; Herrebout, W.; Scippo, M.L.; Blust, R.; Robbens, J. In vitro selection and characterization of DNA aptamers recognizing chloramphenicol. J. Biotechnol 2011, 155, 361–369.
[5]
Wochner, A.; Menger, M.; Orgel, D.; Cech, B.; Rimmele, M.; Erdmann, V.A.; Gl？kler, J. A DNA aptamer with high affinity and specificity for therapeutic anthracyclines. Anal. Biochem 2008, 373, 34–42.
[6]
Shum, K.T.; Lui, E.L.H.; Wong, S.C.K.; Yeung, P.; Sam, L.; Wang, Y.; Watt, R.M.; Tanner, J.A. Aptamer-mediated inhibition of mycobacterium tuberculosis polyphosphate kinase 2. Biochemistry 2011, 50, 3261–3271.
[7]
Stoltenburg, R.; Reinemann, C.; Strehlitz, B. FluMag-SELEX as an advantageous method for DNA aptamer selection. Anal. Bioanal. Chem 2005, 383, 83–91.
[8]
Cao, X.X.; Li, S.H.; Chen, L.C.; Ding, H.M.; Xu, H.; Huang, Y.P.; Li, J.; Liu, N.L.; Cao, W.H.; Zhu, Y.J.; et al. Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureus. Nucleic Acids Res 2009, 37, 4621–4628.
Mascini, M.; Palchetti, I.; Tombelli, S. Nucleic acid and peptide aptamers: Fundamentals and bioanalytical aspects. Angew. Chem. Int. Ed 2012, 51, 1316–1332.
[11]
Bing, T.; Yang, X.; Mei, H.; Cao, Z.; Shangguan, D. Conservative secondary structure motif of streptavidin-binding aptamers generated by different laboratories. Bioorg. Med. Chem 2010, 18, 1798–1805.
[12]
Ruigrok, V.J.B.; van Duijn, E.; Barendregt, A.; Dyer, K.; Tainer, J.A.; Stoltenburg, R.; Strehlitz, B.; Levisson, M.; Smidt, H.; van der Oost, J. Kinetic and stoichiometric characterisation of streptavidin-binding aptamers. ChemBioChem 2012, 13, 829–836.
[13]
Wilson, C.; Nix, J.; Szostak, J. Functional requirements for specific ligand recognition by a biotin- binding RNA pseudoknot. Biochemistry 1998, 37, 14410–14419.
[14]
Kaur, H.; Yung, L.-Y.L. Probing high affinity sequences of DNA aptamer against VEGF 165. PLoS One 2012, 7, e31196.
[15]
Lupold, S.E.; Hicke, B.J.; Lin, Y.; Coffey, D.S. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 2002, 62, 4029–4033.
Hianik, T.; Ostatná, V.; Sonlajtnerova, M.; Grman, I. Influence of ionic strength, pH and aptamer configuration for binding affinity to thrombin. Bioelectrochemistry 2007, 70, 127–133.
[18]
Poniková, S.; Tlu？ková, K.; Antalík, M.; Víglasky, V.; Hianik, T. The circular dichroism and differential scanning calorimetry study of the properties of DNA aptamer dimers. Biophys. Chem 2011, 155, 29–35.
[19]
Reinstein, O.; Neves, M.A.D.; Saad, M.; Boodram, S.N.; Lombardo, S.; Beckham, S.A.; Brouwer, J.; Audette, G.F.; Groves, P.; Wilce, M.C.J.; et al. Engineering a structure switching mechanism into a steroid-binding aptamer and hydrodynamic analysis of the ligand binding mechanism. Biochemistry 2011, 50, 9368–9376.
[20]
Huang, R.H.; Fremont, D.H.; Diener, J.L.; Schaub, R.G.; Sadler, J.E. A structural explanation for the antithrombotic activity of ARC1172, a DNA aptamer that binds von willebrand factor domain A1. Structure 2009, 17, 1476–1484.
[21]
Padmanabhan, K.; Padmanabhan, K.P.; Ferrara, J.D.; Sadler, J.E.; Tulinsky, A. The structure of α-thrombin inhibited by a 15-mer single-stranded DNA aptamer. J. Biol. Chem 1993, 268, 17651–17654.
[22]
Padmanabhan, K.; Tulinsky, A. An ambiguous structure of a DNA 15-mer thrombin complex. Acta Crystallogr. Sect. D 1996, 52, 272–282.
[23]
Long, S.B.; Long, M.B.; White, R.R.; Sullenger, B.A. Crystal structure of an RNA aptamer bound to thrombin. RNA 2008, 14, 2504–2512.
[24]
Krauss, I.R.; Merlino, A.; Giancola, C.; Randazzo, A.; Mazzarella, L.; Sica, F. Thrombin-aptamer recognition: A revealed ambiguity. Nucleic Acids Res 2011, 39, 7858–7867.
[25]
Huang, D.B.; Vu, D.; Cassiday, L.A.; Zimmerman, J.M.; Maher Iii, L.J.; Ghosh, G. Crystal structure of NF-κb (p50)2 complexed to a high-affinity RNA aptamer. Proc. Natl. Acad. Sci. USA 2003, 100, 9268–9273.
[26]
Moorthy, A.K.; Huang, D.B.; Wang, V.Y.F.; Vu, D.; Ghosh, G. X-ray Structure of a NF-κB p50/RelB/DNA complex reveals assembly of multiple dimers on tandem κB sites. J. Mol. Biol 2007, 373, 723–734.
[27]
Someya, T.; Baba, S.; Fujimoto, M.; Kawai, G.; Kumasaka, T.; Nakamura, K. Crystal structure of Hfq from Bacillus subtilis in complex with SELEX-derived RNA aptamer: Insight into RNA-binding properties of bacterial Hfq. Nucleic Acids Res 2012, 40, 1856–1867.
[28]
Nomura, Y.; Sugiyama, S.; Sakamoto, T.; Miyakawa, S.; Adachi, H.; Takano, K.; Murakami, S.; Inoue, T.; Mori, Y.; Nakamura, Y.; et al. Conformational plasticity of RNA for target recognition as revealed by the 2.15 ？ crystal structure of a human IgG-aptamer complex. Nucleic Acids Res 2010, 38, 7822–7829.
Rowsell, S.; Stonehouse, N.J.; Convery, M.A.; Adams, C.J.; Ellington, A.D.; Hirao, I.; Peabody, D.S.; Stockley, P.G.; Phillips, S.E.V. Crystal structures of a series of RNA aptamers complexed to the same protein target. Nat. Struct. Biol 1998, 5, 970–975.
[31]
Horn, W.T.; Convery, M.A.; Stonehouse, N.J.; Adams, C.J.; Liljas, L.; Phillips, S.E.V.; Stockley, P.G. The crystal structure of a high affinity RNA stem-loop complexed with the bacteriophage MS2 capsid: Further challenges in the modeling of ligand-RNA interactions. RNA 2004, 10, 1776–1782.
[32]
Baugh, C.; Grate, D.; Wilson, C. 2.8 ？ Crystal structure of the malachite green aptamer. J. Mol. Biol. 2000, 301, 117–128.
[33]
Sussman, D.; Nix, J.; Wilson, C. The structural basis for molecular recognition by the vitamin B12 RNA aptamer. Nat. Struct. Biol 2000, 7, 53–57.
[34]
Tereshko, V.; Skripkin, E.; Patel, D.J. Encapsulating streptomycin within a small 40-mer RNA. Chem. Biol 2003, 10, 175–187.
[35]
Nix, J.; Sussman, D.; Wilson, C. The 1.3 ？ crystal structure of a biotin-binding pseudoknot and the basis for RNA molecular recognition. J. Mol. Biol 2000, 296, 1235–1244.
[36]
Snyder, D.A.; Chen, Y.; Denissova, N.G.; Acton, T.; Aramini, J.M.; Ciano, M.; Karlin, R.; Liu, J.; Manor, P.; Rajan, P.A.; et al. Comparisons of NMR spectral quality and success in crystallization demonstrate that NMR and X-ray crystallography are complementary methods for small protein structure determination. J. Am. Chem. Soc 2005, 127, 16505–16511.
[37]
Yee, A.A.; Savchenko, A.; Ignachenko, A.; Lukin, J.; Xu, X.; Skarina, T.; Evdokimova, E.; Liu, C.S.; Semesi, A.; Guido, V.; et al. NMR and X-ray crystallography, complementary tools in structural proteomics of small proteins. J. Am. Chem. Soc 2005, 127, 16512–16517.
[38]
Chayen, N.E.; Saridakis, E. Protein crystallization: From purified protein to diffraction-quality crystal. Nat. Methods 2008, 5, 147–153.
[39]
Renault, L.; Chou, H.T.; Chiu, P.L.; Hill, R.M.; Zeng, X.; Gipson, B.; Zhang, Z.Y.; Cheng, A.; Unger, V.; Stahlberg, H. Milestones in electron crystallography. J. Comput. Aided Mol. Des 2006, 20, 519–527.
[40]
Hoggan, D.B.; Chao, J.A.; Prasad, G.S.; Stout, C.D.; Williamson, J.R. Combinatorial crystallization of an RNA-protein complex. Acta Crystallogr. Sect. D 2003, 59, 466–473.
[41]
Hollis, T. Crystallization of protein-DNA complexes. Methods Mol. Biol 2007, 363, 225–237.
[42]
Sugiyama, S.; Nomura, Y.; Sakamoto, T.; Kitatani, T.; Kobayashi, A.; Miyakawa, S.; Takahashi, Y.; Adachi, H.; Takano, K.; Murakami, S.; et al. Crystallization and preliminary X-ray diffraction studies of an RNA aptamer in complex with the human IgG Fc fragment. Acta Crystallogr. Sect. F 2008, 64, 942–944.
[43]
Friedmann, D.; Messick, T.; Marmorstein, R. Crystallization of macromolecules. Curr. Protoc. Protein Sci 2011, 66, 17.4.1–17.4.26.
[44]
McPherson, A. Introduction to protein crystallization. Methods 2004, 34, 254–265.
[45]
Doudna, J.A.; Grosshans, C.; Gooding, A.; Kundrot, C.E. Crystallization of ribozymes and small RNA motifs by a sparse matrix approach. Proc. Natl. Acad. Sci. USA 1993, 90, 7829–7833.
[46]
Ke, A.; Doudna, J.A. Crystallization of RNA and RNA-protein complexes. Methods 2004, 34, 408–414.
[47]
Garber, M.; Gongadze, G.; Meshcheryakov, V.; Nikonov, O.; Nikulin, A.; Perederina, A.; Piendl, W.; Serganov, A.; Tishchenko, S. Crystallization of RNA/protein complexes. Acta Crystallogr. Sect. D 2002, 58, 1664–1669.
[48]
Bock, L.C.; Griffin, L.C.; Latham, J.A.; Vermaas, E.H.; Toole, J.J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992, 355, 564–566.
[49]
Skrzypczak-Jankun, E.; Carperos, V.E.; Ravichandran, K.G.; Tulinsky, A.; Westbrook, M.; Maraganore, J.M. Structure of the hirugen and hirulog 1 complexes of α-thrombin. J. Mol. Biol 1991, 221, 1379–1393.
[50]
Macaya, R.F.; Schultze, P.; Smith, F.W.; Roe, J.A.; Feigon, J. Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution. Proc. Natl. Acad. Sci. USA 1993, 90, 3745–3749.
[51]
Wang, K.Y.; McCurdy, S.; Shea, R.G.; Swaminathan, S.; Bolton, P.H. A DNA aptamer which binds to and inhibits thrombin exhibits a new structural motif for DNA. Biochemistry 1993, 32, 1899–1904.
[52]
Kelly, J.A.; Feigon, J.; Yeates, T.O. Reconciliation of the X-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG). J. Mol. Biol 1996, 256, 417–422.
[53]
Miyakawa, S.; Nomura, Y.; Sakamoto, T.; Yamaguchi, Y.; Kato, K.; Yamazaki, S.; Nakamura, Y. Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G. RNA 2008, 14, 1154–1163.
[54]
Murai, R.; Yoshikawa, H.Y.; Kawahara, H.; Maki, S.; Sugiyama, S.; Kitatani, T.; Adachi, H.; Takano, K.; Matsumura, H.; Murakami, S.; et al. Effect of solution flow produced by rotary shaker on protein crystallization. J. Cryst. Growth 2008, 310, 2168–2172.
[55]
Jiang, X.; Egli, M. Use of Chromophoric Ligands to Visually Screen Co-Crystals of Putative Protein-Nucleic Acid Complexes. Curr. Protoc. Nucleic Acid Chem 2011, 7, 7.15.1–7.15.8.
[56]
Gold, L.; Janjic, N.; Jarvis, T.; Schneider, D.; Walker, J.J.; Wilcox, S.K.; Zichi, D. Aptamers and the RNA world, past and present. Cold Spring Harb. Perspect. Biol 2012, 4, doi:10.1101/cshperspect.a003582.
[57]
Win, M.N.; Klein, J.S.; Smolke, C.D. Codeine-binding RNA aptamers and rapid determination of their binding constants using a direct coupling surface plasmon resonance assay. Nucleic Acids Res 2006, 34, 5670–5682.
[58]
Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003, 31, 3406–3415.
[59]
Rivas, E.; Eddy, S.R. A dynamic programming algorithm for RNA structure prediction including pseudoknots. J. Mol. Biol 1999, 285, 2053–2068.
[60]
Kikin, O.; D’Antonio, L.; Bagga, P.S. QGRS Mapper: A web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res 2006, 34, W676–W682.
[61]
Laing, C.; Schlick, T. Computational approaches to RNA structure prediction, analysis, and design. Curr. Opin. Struct. Biol 2011, 21, 306–318.
[62]
Parisien, M.; Major, F. The MC-Fold and MC-Sym pipeline infers RNA structure from sequence data. Nature 2008, 452, 51–55.
[63]
Sekiya, S.; Noda, K.; Nishikawa, F.; Yokoyama, T.; Kumar, P.K.R.; Nishikawa, S. Characterization and application of a novel RNA aptamer against the mouse prion protein. J. Biochem (Tokyo) 2006, 139, 383–390.
[64]
Lebruska, L.L.; Maher Iii, L.J. Selection and characterization of an RNA decoy for transcription factor NF-κB. Biochemistry 1999, 38, 3168–3174.
[65]
Hwang, J.; Fauzi, H.; Fukuda, K.; Sekiya, S.; Kakiuchi, N.; Shimotohno, K.; Taira, K.; Kusakabe, I.; Nishikawa, S. The RNA aptamer-binding site of hepatitis C virus NS3 protease. Biochem. Biophys. Res. Commun 2000, 279, 557–562.
[66]
Yan, X.; Maier, C.S. Hydrogen/Deuterium Exchange Mass Spectrometry. In Mass Spectrometry of Proteins and Peptides; Lipton, M.S., Pa？a-Tolic, L., Eds.; Humana Press: New York, NY, USA, 2009; Volume 492, pp. 255–271.
[67]
Reinemann, C.; Stoltenburg, R.; Strehlitz, B. Investigations on the specificity of DNA aptamers binding to ethanolamine. Anal. Chem 2009, 81, 3973–3978.
[68]
Kwan, A.H.; Mobli, M.; Gooley, P.R.; King, G.F.; MacKay, J.P. Macromolecular NMR spectroscopy for the non-spectroscopist. FEBS J 2011, 278, 687–703.
[69]
Orlova, E.V.; Saibil, H.R. Structural analysis of macromolecular assemblies by electron microscopy. Chem. Rev 2011, 111, 7710–7748.
